Heart Health
Johns Hopkins Tests Deliberate Pacing Trick to Rescue Failing Hearts
A pilot trial explores whether intentionally inducing brief daily dyssynchrony via pacemaker can retrain failing heart muscle in humans.
Clinical Trial
Jun 14, 2026 0
Heart Disease
675 articles in this topic
Heart Health
High Salt Diet Triggers Aortic Dissection Through a Hidden Mitochondrial Pathway
Researchers discover that salt-triggered aortic dissection hinges on a receptor that guards mitochondrial energy metabolism in vessel walls.
Research Paper
Jun 14, 2026 0
Heart Health
FDA Approves Aficamten for Obstructive Hypertrophic Cardiomyopathy
Myqorzo (aficamten) wins FDA approval for symptomatic obstructive HCM, offering a novel cardiac myosin inhibitor option for patients.
Drug Approval
Jun 14, 2026 0
Heart Health
Phase 3 Trial Tests Tafamidis for TTR Amyloid Heart Disease
Pfizer's landmark trial examines whether tafamidis can safely treat transthyretin amyloid cardiomyopathy, a progressive and often fatal heart condition.
Clinical Trial
Jun 13, 2026 0
Heart Health
Telepharmacy Cuts Blood Pressure and Boosts Medication Adherence in Chronic Disease Patients
A Cochrane review of 21 RCTs finds remote pharmacist care may improve adherence and lower blood pressure in NCD patients.
Review
Jun 13, 2026 0
Heart Health
Common Food Additives Linked to Higher Hypertension and CVD Risk
New JAMA research ties widely used food additives to elevated blood pressure and cardiovascular disease risk.
Research Paper
Jun 13, 2026 0
Heart Health
Monthly Shot vs Twice-Yearly Injection Battle for LDL Dominance in High-Risk Patients
Phase 3 trial pits lerodalcibep against inclisiran to determine which PCSK9 inhibitor best cuts LDL in cardiovascular high-risk patients.
Clinical Trial
Jun 12, 2026 0
Heart Health
Resmetirom Targets LDL Cholesterol in Familial Hypercholesterolemia Trial
A Phase 2 trial tests once-daily oral resmetirom (MGL-3196) against placebo to reduce LDL-C in patients with inherited high cholesterol.
Clinical Trial
Jun 12, 2026 0
Heart Health
Phase 3 Trial Tests Obicetrapib for Hard-to-Treat High Cholesterol
A completed Phase 3 trial evaluates obicetrapib added to maximum lipid-lowering therapy in patients with familial hypercholesterolemia and ASCVD.
Clinical Trial
Jun 12, 2026 0
Heart Health
9-Apolipoprotein Blood Panel Outperforms Standard Cholesterol Tests for Heart Attack Risk
A mass spectrometry apolipoprotein panel predicts cardiovascular events and identifies who gains the most from PCSK9 inhibitor therapy.
Research Paper
Jun 12, 2026 0
Heart Health
Hidden Heart Risk: Remnant Cholesterol Raises ASCVD Risk More Than LDL But Gets Undertreated
A 94,000-person study finds high remnant cholesterol raises heart disease risk 45% — yet triggers far less statin prescribing than high LDL.
Research Paper
Jun 12, 2026 0
Heart Health
Heart Protein RND3 Shields Against Heart Attack Damage by Fixing Fuel Metabolism
A newly discovered mitochondrial protein boosts cardiac glucose burning and dramatically reduces heart injury after ischemia-reperfusion.
Research Paper
Jun 12, 2026 0